annual FCF:
$259.90M-$369.60M(-58.71%)Summary
- As of today (June 22, 2025), EW annual free cash flow is $259.90 million, with the most recent change of -$369.60 million (-58.71%) on December 31, 2024.
- During the last 3 years, EW annual FCF has fallen by -$1.14 billion (-81.47%).
- EW annual FCF is now -81.47% below its all-time high of $1.40 billion, reached on December 31, 2021.
Performance
EW Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$224.40M+$406.30M(+223.36%)Summary
- As of today (June 22, 2025), EW quarterly free cash flow is $224.40 million, with the most recent change of +$406.30 million (+223.36%) on March 1, 2025.
- Over the past year, EW quarterly FCF has increased by +$363.20 million (+261.67%).
- EW quarterly FCF is now -70.55% below its all-time high of $762.00 million, reached on June 30, 2014.
Performance
EW quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$623.10M+$363.20M(+139.75%)Summary
- As of today (June 22, 2025), EW TTM free cash flow is $623.10 million, with the most recent change of +$363.20 million (+139.75%) on March 1, 2025.
- Over the past year, EW TTM FCF has increased by +$371.90 million (+148.05%).
- EW TTM FCF is now -56.38% below its all-time high of $1.43 billion, reached on March 31, 2022.
Performance
EW TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
EW Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -58.7% | +261.7% | +148.1% |
3 y3 years | -81.5% | +1.7% | -56.4% |
5 y5 years | -71.3% | +79.7% | -42.7% |
EW Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -81.5% | at low | -37.0% | +223.4% | -56.4% | +148.1% |
5 y | 5-year | -81.5% | at low | -52.4% | +223.4% | -56.4% | +148.1% |
alltime | all time | -81.5% | +312.5% | -70.5% | +223.4% | -56.4% | >+9999.0% |
EW Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $224.40M(-223.4%) | $623.10M(+139.7%) |
Dec 2024 | $259.90M(-58.7%) | -$181.90M(-161.8%) | $259.90M(-47.0%) |
Sep 2024 | - | $294.50M(+2.9%) | $490.10M(-11.2%) |
Jun 2024 | - | $286.10M(-306.1%) | $551.80M(+119.7%) |
Mar 2024 | - | -$138.80M(-387.4%) | $251.20M(-60.1%) |
Dec 2023 | $629.50M(-34.0%) | $48.30M(-86.4%) | $629.50M(-18.8%) |
Sep 2023 | - | $356.20M(-2556.6%) | $774.90M(+15.9%) |
Jun 2023 | - | -$14.50M(-106.1%) | $668.70M(-31.2%) |
Mar 2023 | - | $239.50M(+23.6%) | $972.30M(+2.0%) |
Dec 2022 | $953.40M(-32.0%) | $193.70M(-22.5%) | $953.40M(-8.3%) |
Sep 2022 | - | $250.00M(-13.5%) | $1.04B(-17.5%) |
Jun 2022 | - | $289.10M(+31.1%) | $1.26B(-11.7%) |
Mar 2022 | - | $220.60M(-21.2%) | $1.43B(+1.9%) |
Dec 2021 | $1.40B(+116.7%) | $279.80M(-40.6%) | $1.40B(-0.5%) |
Sep 2021 | - | $471.20M(+3.2%) | $1.41B(+34.1%) |
Jun 2021 | - | $456.80M(+134.9%) | $1.05B(+46.6%) |
Mar 2021 | - | $194.50M(-32.1%) | $716.60M(+10.8%) |
Dec 2020 | $647.00M(-28.5%) | $286.30M(+153.8%) | $647.00M(-6.5%) |
Sep 2020 | - | $112.80M(-8.3%) | $692.10M(-26.4%) |
Jun 2020 | - | $123.00M(-1.5%) | $940.50M(-13.5%) |
Mar 2020 | - | $124.90M(-62.3%) | $1.09B(+20.2%) |
Dec 2019 | $904.50M(+32.0%) | $331.40M(-8.3%) | $904.50M(+11.9%) |
Sep 2019 | - | $361.20M(+34.1%) | $808.40M(+14.8%) |
Jun 2019 | - | $269.40M(-568.5%) | $704.40M(+34.8%) |
Mar 2019 | - | -$57.50M(-124.4%) | $522.40M(-23.7%) |
Dec 2018 | $685.00M(-17.0%) | $235.30M(-8.5%) | $685.00M(-9.2%) |
Sep 2018 | - | $257.20M(+194.3%) | $754.30M(-2.3%) |
Jun 2018 | - | $87.40M(-16.8%) | $772.00M(-5.9%) |
Mar 2018 | - | $105.10M(-65.5%) | $820.60M(-0.6%) |
Dec 2017 | $825.20M(+69.4%) | $304.60M(+10.8%) | $825.20M(+25.3%) |
Sep 2017 | - | $274.90M(+102.1%) | $658.50M(+21.7%) |
Jun 2017 | - | $136.00M(+24.0%) | $541.20M(+4.6%) |
Mar 2017 | - | $109.70M(-20.4%) | $517.30M(+6.2%) |
Dec 2016 | $487.00M(+9.9%) | $137.90M(-12.5%) | $487.00M(+18.3%) |
Sep 2016 | - | $157.60M(+40.6%) | $411.60M(-4.4%) |
Jun 2016 | - | $112.10M(+41.2%) | $430.50M(-8.4%) |
Mar 2016 | - | $79.40M(+27.0%) | $470.10M(+6.1%) |
Dec 2015 | $443.20M(-52.3%) | $62.50M(-64.6%) | $443.20M(+3.4%) |
Sep 2015 | - | $176.50M(+16.3%) | $428.60M(+74.1%) |
Jun 2015 | - | $151.70M(+189.0%) | $246.20M(-71.3%) |
Mar 2015 | - | $52.50M(+9.6%) | $856.50M(-7.8%) |
Dec 2014 | $928.60M(+156.1%) | $47.90M(-911.9%) | $928.60M(-4.3%) |
Sep 2014 | - | -$5.90M(-100.8%) | $970.80M(-10.6%) |
Jun 2014 | - | $762.00M(+511.6%) | $1.09B(+156.9%) |
Mar 2014 | - | $124.60M(+38.3%) | $422.90M(+16.6%) |
Dec 2013 | $362.60M(+47.3%) | $90.10M(-17.8%) | $362.60M(+5.7%) |
Sep 2013 | - | $109.60M(+11.2%) | $343.10M(+1.2%) |
Jun 2013 | - | $98.60M(+53.3%) | $339.10M(-5.6%) |
Mar 2013 | - | $64.30M(-8.9%) | $359.10M(+45.9%) |
Dec 2012 | $246.10M | $70.60M(-33.1%) | $246.10M(+3.6%) |
Sep 2012 | - | $105.60M(-11.0%) | $237.50M(+4.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | $118.60M(-343.5%) | $227.80M(+30.5%) |
Mar 2012 | - | -$48.70M(-178.5%) | $174.50M(-22.1%) |
Dec 2011 | $223.90M(+18.8%) | $62.00M(-35.3%) | $223.90M(-4.4%) |
Sep 2011 | - | $95.90M(+46.9%) | $234.20M(+7.3%) |
Jun 2011 | - | $65.30M(+9228.6%) | $218.30M(+17.8%) |
Mar 2011 | - | $700.00K(-99.0%) | $185.30M(-1.6%) |
Dec 2010 | $188.40M(+86.0%) | $72.30M(-9.6%) | $188.40M(+19.0%) |
Sep 2010 | - | $80.00M(+147.7%) | $158.30M(+15.0%) |
Jun 2010 | - | $32.30M(+750.0%) | $137.70M(-9.5%) |
Mar 2010 | - | $3.80M(-91.0%) | $152.20M(+50.2%) |
Dec 2009 | $101.30M(+34.7%) | $42.20M(-29.0%) | $101.30M(+6.7%) |
Sep 2009 | - | $59.40M(+26.9%) | $94.90M(+155.8%) |
Jun 2009 | - | $46.80M(-199.4%) | $37.10M(+408.2%) |
Mar 2009 | - | -$47.10M(-231.6%) | $7.30M(-90.3%) |
Dec 2008 | $75.20M(-49.1%) | $35.80M(+2137.5%) | $75.20M(-23.2%) |
Sep 2008 | - | $1.60M(-90.6%) | $97.90M(-30.1%) |
Jun 2008 | - | $17.00M(-18.3%) | $140.00M(-4.1%) |
Mar 2008 | - | $20.80M(-64.4%) | $146.00M(-1.2%) |
Dec 2007 | $147.70M(-13.8%) | $58.50M(+33.9%) | $147.70M(+4.2%) |
Sep 2007 | - | $43.70M(+90.0%) | $141.80M(+1.1%) |
Jun 2007 | - | $23.00M(+2.2%) | $140.30M(-1.9%) |
Mar 2007 | - | $22.50M(-57.2%) | $143.00M(-16.6%) |
Dec 2006 | $171.40M(+99.8%) | $52.60M(+24.6%) | $171.40M(+23.6%) |
Sep 2006 | - | $42.20M(+64.2%) | $138.70M(+11.2%) |
Jun 2006 | - | $25.70M(-49.5%) | $124.70M(+2.4%) |
Mar 2006 | - | $50.90M(+155.8%) | $121.80M(+42.0%) |
Dec 2005 | $85.80M(-37.9%) | $19.90M(-29.4%) | $85.80M(-11.6%) |
Sep 2005 | - | $28.20M(+23.7%) | $97.10M(-20.0%) |
Jun 2005 | - | $22.80M(+53.0%) | $121.30M(-0.4%) |
Mar 2005 | - | $14.90M(-52.2%) | $121.80M(-11.8%) |
Dec 2004 | $138.10M(+32.5%) | $31.20M(-40.5%) | $138.10M(-24.7%) |
Sep 2004 | - | $52.40M(+124.9%) | $183.30M(+10.0%) |
Jun 2004 | - | $23.30M(-25.3%) | $166.60M(+19.0%) |
Mar 2004 | - | $31.20M(-59.2%) | $140.00M(+34.4%) |
Dec 2003 | $104.20M(+30.4%) | $76.40M(+114.0%) | $104.20M(+76.0%) |
Sep 2003 | - | $35.70M(-1181.8%) | $59.20M(+29.5%) |
Jun 2003 | - | -$3.30M(-28.3%) | $45.70M(-45.5%) |
Mar 2003 | - | -$4.60M(-114.6%) | $83.80M(+4.9%) |
Dec 2002 | $79.90M(+26.8%) | $31.40M(+41.4%) | $79.90M(-6.1%) |
Sep 2002 | - | $22.20M(-36.2%) | $85.10M(+5.8%) |
Jun 2002 | - | $34.80M(-509.4%) | $80.40M(+12.9%) |
Mar 2002 | - | -$8.50M(-123.2%) | $71.20M(+13.0%) |
Dec 2001 | $63.00M(-30.8%) | $36.60M(+109.1%) | $63.00M(-2.8%) |
Sep 2001 | - | $17.50M(-31.6%) | $64.80M(-14.6%) |
Jun 2001 | - | $25.60M(-253.3%) | $75.90M(+9.5%) |
Mar 2001 | - | -$16.70M(-143.5%) | $69.30M(-23.8%) |
Dec 2000 | $91.00M(-32.1%) | $38.40M(+34.3%) | $91.00M(+73.0%) |
Sep 2000 | - | $28.60M(+50.5%) | $52.60M(+119.2%) |
Jun 2000 | - | $19.00M(+280.0%) | $24.00M(+380.0%) |
Mar 2000 | - | $5.00M | $5.00M |
Dec 1999 | $134.00M | - | - |
FAQ
- What is Edwards Lifesciences annual free cash flow?
- What is the all time high annual FCF for Edwards Lifesciences?
- What is Edwards Lifesciences annual FCF year-on-year change?
- What is Edwards Lifesciences quarterly free cash flow?
- What is the all time high quarterly FCF for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly FCF year-on-year change?
- What is Edwards Lifesciences TTM free cash flow?
- What is the all time high TTM FCF for Edwards Lifesciences?
- What is Edwards Lifesciences TTM FCF year-on-year change?
What is Edwards Lifesciences annual free cash flow?
The current annual FCF of EW is $259.90M
What is the all time high annual FCF for Edwards Lifesciences?
Edwards Lifesciences all-time high annual free cash flow is $1.40B
What is Edwards Lifesciences annual FCF year-on-year change?
Over the past year, EW annual free cash flow has changed by -$369.60M (-58.71%)
What is Edwards Lifesciences quarterly free cash flow?
The current quarterly FCF of EW is $224.40M
What is the all time high quarterly FCF for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly free cash flow is $762.00M
What is Edwards Lifesciences quarterly FCF year-on-year change?
Over the past year, EW quarterly free cash flow has changed by +$363.20M (+261.67%)
What is Edwards Lifesciences TTM free cash flow?
The current TTM FCF of EW is $623.10M
What is the all time high TTM FCF for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM free cash flow is $1.43B
What is Edwards Lifesciences TTM FCF year-on-year change?
Over the past year, EW TTM free cash flow has changed by +$371.90M (+148.05%)